PATENT CLAIM ANALYSIS

Application Number: 15753324
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["424", "216100"]

Abstract:
The present invention encompasses FCV vaccines or compositions. The vaccine or composition may be a vaccine or composition containing FCV antigens. The invention also encompasses recombinant vectors encoding and expressing FCV antigens, epitopes or immunogens which can be used to protect animals against FCV infection.

Claim (Index 13):
A substantially purified FCV empty capsid or FCV VLP expressed in insect cells, wherein the FCV empty capsid or VLP comprises a polypeptide having at least 90% sequence identity to the sequence as set forth in SEQ ID NO: 3 or 4, wherein the insect cells are inactivated and cell debris are removed.

Metadata:
- Claim Count in Document: 13.0
- Percentile: 88.0
- Lexical Diversity: 1.48485
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14863181', '11494825', '12824287', '15265545', '11040670']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7972172757007004
- 35 USC 102 Novelty (BERT): 0.5329473385706713
- Combined Prediction Score: 0.7707902819876976
- Mean Citation Score: 335.9215000000001
- Max Citation Score: 366.13083
- Similarity Product: 293.976204302634

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test